US 9206421
Lipid formulated compositions and methods for inhibiting expression of serum amyloid A gene
granted A61KA61K31/713A61P
Quick answer
US patent 9206421 (Lipid formulated compositions and methods for inhibiting expression of serum amyloid A gene) held by Alnylam Pharmaceuticals, Inc. expires Mon Dec 03 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Alnylam Pharmaceuticals, Inc.
- Grant date
- Tue Dec 08 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 03 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K31/713, A61P, A61P1/00, A61P1/04